Suspicion of the presence of N-nitrosodimethylamine (NDMA) contamination in medicinal products with Ranitidinum, which may affect human health and life and poses a potential risk to patients. Potential effects: poisoning, carcinogenic effects, systemic complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use medicinal products containing Ranitidinum from the affected products/batches, check the medicine name and, in case of doubt, consult a doctor or pharmacist.
The Chief Pharmaceutical Inspector preventively suspended from the market all medicinal products containing the active substance Ranitidinum, granting the decision immediate enforceability, and oblige...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related